EMEA-002033-PIP01-16-M03

Table of contents

Key facts

Invented name
Voxzogo
Active substance
Vosoritide
Therapeutic area
Other
Decision number
P/0453/2022
PIP number
EMEA-002033-PIP01-16-M03
Pharmaceutical form(s)
Powder for solution for injection
Condition(s) / indication(s)
Treatment of achondroplasia
Route(s) of administration
Subcutaneous use
Contact for public enquiries
BioMarin International Limited

Tel. +44 (0)20 7420 0800
E-mail: biomarin-europe@bmrn.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

Related content

How useful was this page?

Add your rating